Table 3.
Bivariate Analysis | Multivariable Analysis | |||
---|---|---|---|---|
Variable | HR (95% CI) | p-Value | HR (95% CI) | p Value |
Age >60 years | 2.84 (1.60–5.05) | <0.01 | 3.47 (1.38–8.68) | <0.01 |
Sex (Male) | 0.79 (0.46–1.36) | 0.39 | 0.65 (0.28–1.54) | 0.33 |
Body mass index | 0.87 (0.50–1.50) | 0.61 | ||
MELD-Na score >30 | 1.70 (0.94–3.04) | 0.08 | 1.02 (0.97–1.06) | 0.47 |
Hepatocellular carcinoma | 1.48 (0.85–2.55) | 0.16 | ||
Alcohol-related cirrhosis | 0.75 (0.47–1.19) | 0.22 | ||
Vitamin D sufficiency, Pre-transplant | 1.15 (0.65–2.03) | 0.63 | 1.02 (0.42–2.44) | 0.97 |
Vitamin D sufficiency, Post-transplant | 0.44 (0.21–0.96) | 0.04 | 0.31 (0.13–0.75) | <0.01 |
Vitamin D supplementation, Pre-transplant | 1.28 (0.71–2.32) | 0.41 | ||
Vitamin D supplementation, Post-transplant | 0.92 (0.53–1.61) | 0.78 | ||
Crossmatch for T or B cell positive | 1.26 (0.85–1.87) | 0.26 |
CI: confidence interval; HR: hazard ratio; MELD-Na: model for end-stage liver disease.